Troxip-OD Tablet PR

Introduction

Troxip-OD PR is a prescription medication that contains the active ingredient Troxipide. It is available in tablet form and is commonly known by its brand name, Troxip-OD PR. This medication is primarily used to treat certain gastrointestinal disorders.

Uses

Troxip-OD PR is prescribed to individuals who are experiencing symptoms of gastritis, gastric and duodenal ulcers, and other similar conditions. It helps to alleviate pain, reduce inflammation, and promote healing in the stomach and intestines.

Dosage and Administration

The dosage of Troxip-OD PR may vary depending on the severity of the condition and the individual’s response to treatment. Follow the instructions provided by your healthcare professional. Generally, the recommended dose for adults is one tablet taken once daily with a meal.

The tablet should be swallowed whole with a glass of water and should not be crushed, chewed, or broken. If you have difficulty swallowing the tablet, please consult your healthcare professional for alternative options.

Mechanism of Action

Troxipide, the active ingredient in Troxip-OD PR, works by protecting the stomach and intestinal lining from damage caused by gastric acid, inflammation, and other factors. It helps to enhance the natural defense mechanisms of the gastrointestinal tract, promoting healing and reducing symptoms.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort. These side effects are generally mild and may resolve on their own. If they persist or become bothersome, it is recommended to consult your healthcare professional.

In rare cases, more serious side effects may occur. These can include allergic reactions, such as rash, itching, swelling, dizziness, or difficulty breathing. If you experience any of these symptoms, seek immediate medical attention.

Drug Interactions

Troxip-OD PR may interact with certain medications, which can affect its effectiveness or increase the risk of side effects. Inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and dietary supplements.

Some medications that may interact with Troxip-OD PR include antacids, proton pump inhibitors, and certain antibiotics. Your healthcare professional will be able to provide guidance on potential drug interactions and adjust your treatment plan accordingly.

Precautions

Before starting Troxip-OD PR, inform your healthcare professional about any existing medical conditions, allergies, or sensitivities you may have. Note that this medication is contraindicated in individuals with a known hypersensitivity to Troxipide or any other component of the product.

Additionally, Troxip-OD PR should be used with caution in individuals with liver or kidney impairment. Close monitoring by a healthcare professional may be necessary in these cases.

Storage

Troxip-OD PR should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Troxip-OD PR with a meal to help reduce the risk of stomach upset.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Do not exceed the recommended dosage unless directed by your healthcare professional.
• If you have any concerns or questions about your treatment with Troxip-OD PR, do not hesitate to consult your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Cooper E, Choi PJ, Schweder P, Mee E, Turner C, Faull R, Denny WA, Dragunow M, I-H Park T, Jose J. Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines. Bioorg Med Chem Lett. 2021 Oct 15;50:128336. doi: 10.1016/j.bmcl.2021.128336. Epub 2021 Aug 24. [Accessed 7 Jun. 2024] Available at:
• Momo K, Hoshina K, Ishibashi Y, Saito T. [Preventive effects of troxipide on a newly developed model of acute gastric mucosal lesion (AGML) induced by ischemia/reperfusion plus ammonia in the rat]. Nihon Yakurigaku Zasshi. 1994 Oct;104(4):313-23. doi: 10.1254/fpj.104.313. [Accessed 27 Jun. 2024] Available at:
• Gao Y, Gao Y, Yin F, Wang M, Wang Z, Ye T, Yang Y, Pan WS, Yang X. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide. Drug Dev Ind Pharm. 2015;41(9):1443-51. doi: 10.3109/03639045.2014.956113. Epub 2015 Jul 21. [Accessed 1 Jun. 2024] Available at:
• Lu N, Huo JL, Wang S, Yuan XH, Liu HM. Drug repurposing: Discovery of troxipide analogs as potent antitumor agents. Eur J Med Chem. 2020 Sep 15;202:112471. doi: 10.1016/j.ejmech.2020.112471. Epub 2020 Jun 26. [Accessed 8 Jun. 2024] Available at: